Ghrelin levels are reduced in Rett syndrome patients with eating difficulties
Authors:
- Yoshihiro NishiYNYoshihiro Nishi
- Yushiro YamashitaYYYushiro Yamashita
- Satoru TakahashiSTSatoru Takahashi
- Shin‐Ichiro NagamitsuSNShin‐Ichiro Nagamitsu
- Tatsuyuki KakumaTKTatsuyuki Kakuma
- Hiroshi HosodaHHHiroshi Hosoda
- Kenji KangawaKKKenji Kangawa
- Masayasu KojimaMKMasayasu Kojima
- Toyojiro MatsuishiTMToyojiro Matsuishi
- 18 July 2011
- journal article
- research article
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 29 (8) , 899-902
Abstract
Most patients with Rett syndrome (RTT) have both gastrointestinal problems and somatic growth failure, including microcephaly. Ghrelin is a peptide hormone involved in growth hormone secretion, interdigestive motility, and feeding behavior. Plasma ghrelin assays have previously been described for other neurodevelopmental disorders. To examine the pathophysiology of RTT, we measured plasma levels of ghrelin in patients with RTT. A case–control study examining plasma levels of ghrelin, serum growth hormone, and insulin‐like growth factor‐1 (IGF‐1) was performed on 27 patients with RTT and 53 controls. Plasma levels of total (T)‐ and octanoyl (O)‐ghrelin were significantly lower in patients with RTT than in controls. Plasma levels of T‐ghrelin correlated significantly with serum IGF‐1 levels and head circumference. Significantly lower levels of plasma T‐ghrelin and O‐ghrelin were observed in RTT patients with eating difficulties, while lower levels of plasma T‐ghrelin were observed in RTT patients with constipation, in comparison to patients without either of these symptoms. Alterations in plasma ghrelin levels may reflect various clinical symptoms and signs in RTT patients, including growth failure, acquired microcephalus, autonomic nerve dysfunction, and feeding difficulties. We describe the role of ghrelin in RTT and suggest this peptide as a novel biological marker in patients with RTT.Keywords
Funding Information
- Japan Society for the Promotion of Science (21591338)
This publication has 15 references indexed in Scilit:
- Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalitiesProceedings of the National Academy of Sciences, 2009
- Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamusHuman Molecular Genetics, 2009
- Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigraExperimental Neurology, 2008
- Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite.European Journal of Endocrinology, 2008
- The autonomic nervous system regulates gastric ghrelin secretion in ratsRegulatory Peptides, 2008
- Feeding Experiences and Growth Status in a Rett Syndrome PopulationJournal of Pediatric Gastroenterology and Nutrition, 2007
- Comparison of the World Health Organization (WHO) Child Growth Standards and the National Center for Health Statistics/WHO international growth reference: implications for child health programmesPublic Health Nutrition, 2006
- Ghrelin: Structure and FunctionPhysiological Reviews, 2005
- Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptorProceedings of the National Academy of Sciences, 2004
- Ghrelin and Des-acyl Ghrelin: Two Major Forms of Rat Ghrelin Peptide in Gastrointestinal TissueBiochemical and Biophysical Research Communications, 2000